Cryoport(NASDAQ) CYRX

Current Price$15.35

Market Cap$774.68M

Since IPO (2005)-86%

5 Year-74%

1 Year+93%

1 Month-1%

Cryoport last closing stock price
Metric	Price	Date
Last close	USD 15.37	2026-07-24

Cryoport stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-6.9%	USD 16.51	2026-07-17
1 month	-0.97%	USD 15.52	2026-06-24
3 month	+45.14%	USD 10.59	2026-04-24
Year to date	+60.1%	USD 9.60	2025-12-31
1 year	+92.61%	USD 7.98	2025-07-24
3 year	-3.82%	USD 15.98	2023-07-25
5 year	-74.25%	USD 59.70	2021-07-23
Since inception	-86.15%	USD 111.00	2005-01-31

Cryoport Financials at a Glance

Market Cap

$774.68M

Revenue (TTM)

$182.94M

Net Income (TTM)

$77.16M

EPS (TTM)

-$0.88

P/E Ratio

-17.43

Dividend

$0.00

Beta (Volatility)

1.93 (High)

Dividend

$0.00

Beta (Volatility)

1.93 (High)

Price

$15.35

Volume

22,050

Open

$16.34

Price

$15.35

Volume

22,050

Open

$16.34

Previous Close

$15.35

Daily Range

$15.33 - $16.45

52-Week Range

$6.69 - $16.89

Estimated Earnings Date

Aug 4, 2026

Dividend

$0.00

Beta (Volatility)

1.93 (High)

Price

$15.35

Volume

22,050

Open

$16.34

Previous Close

$15.35

Daily Range

$15.33 - $16.45

52-Week Range

$6.69 - $16.89

Estimated Earnings Date

Aug 4, 2026

CYRX News

Why Cryoport Stock Is Up 39% Since Yesterday and Chart Industries Stock is Down

Jason HallAug 26, 2020

Chalkboard drawing of stock chart arrow going up being erased and pointing back down

Why Cryoport Stock Just Dropped 16%

Rich SmithJan 10, 2020

CYRX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cryoport

Cryoport helps medical companies move and store fragile living cells. These materials must stay frozen to work correctly for patients. The company serves the growing world of advanced gene treatments.

How They Help

BioLogistics Solutions: Temperature-controlled shipping for fragile medicines; part of the services segment that was 54.8% of 2025 revenue.
Cryogenic Systems: Freezers that use liquid nitrogen to store materials at extremely low temperatures; accounts for 45.2% of 2025 revenue.
BioStorage and BioServices: Secure freezing and packaging for medical samples used in clinical trials and commercial research.
Cryopreservation: Standardized freezing of cell materials, which are the building blocks for advanced medical treatments.

Scaling the Global Network

Divested the CRYOPDP specialty courier business to DHL for $133 million in Q2 2025.
Established a partnership with DHL Group to support expansion in Europe and the Asia Pacific region.
Launched the IntegriCell platform in late 2024 to automate how living cells are frozen for therapy.
Opened a new global supply chain center in Paris, France, in November 2025.

Ensuring Medical Safety

Cryoport uses a Chain of Compliance system to track the health and identity of shipped materials. This data-driven platform monitors temperature and handling to meet strict medical safety rules for cell and gene therapies.

The Financial Record

Revenue reached $47.8 million in Q1 2026, up 16.5% year-over-year.
Net income was -$12.5 million in Q1 2026, which worsened 4.7% year-over-year.
Total revenue hit $176.2 million in 2025, up 12.4% from 2024.
Gross profit reached $21.9 million in Q1 2026, up 17.6% year-over-year.

Evolution of the Business

Cryoport has moved from providing individual shipping containers to offering a complete supply chain for high-value therapies. Its growth is tied to the increasing number of approved cell and gene treatments worldwide.

AI Generated • May 5, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

738

CEO

Jerrell W. Shelton, MBA

Website

www.cryoportinc.com

Headquarters

Brentwood, TN 37027, US

CYRX Financials

Key Financial Metrics (TTM)

Gross Margin

47.19%

Operating Margin

-21.44%

Net Income Margin

42.18%

Return on Equity

16.16%

Return on Capital

-5.02%

Return on Assets

10.10%

Earnings Yield

-5.74%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$774.68M

Shares Outstanding

50.40M

Volume

22.05K

Avg. Volume

828.70K

Financials (TTM)

Gross Profit

$86.33M

Operating Income

-$39.23M

EBITDA

-$6.31M

Operating Cash Flow

-$503.00K

Capital Expenditure

-$23.86M

Free Cash Flow

-$24.36M

Cash & ST Invst.

$403.63M

Total Debt

$230.49M

Cryoport Performance Analysis

Cryoport annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 237,277,000	6.6%
2023	2023-12-31	USD 233,255,000	-1.7%
2024	2024-12-31	USD 156,769,000	-32.8%
2025	2025-12-31	USD 176,177,000	12.4%

Cryoport sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	10.8%
Q3	2025-09-30	-2.7%
Q4	2025-12-31	2.8%
Q1	2026-03-31	5.2%

Cryoport annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -0.93	-85.0%
2023	2023-12-31	USD -2.21	138.5%
2024	2024-12-31	USD -2.49	12.7%
2025	2025-12-31	USD -0.93	-62.5%

Cryoport sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	832.1%
Q3	2025-09-30	-108.8%
Q4	2025-12-31	-16.7%
Q1	2026-03-31	-9.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$47.80M

+16.5%

Gross Profit

$21.91M

+17.6%

Gross Margin

45.85%

N/A

Market Cap

$774.68M

N/A

Market Cap/Employee

$1.05M

N/A

Employees

738

N/A

Net Income

-$9.43M

+21.3%

EBITDA

-$2.49M

-340.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$403.63M

+65.4%

Total Debt

$230.49M

-5.0%

Accounts Receivable

$39.00M

+37.5%

Inventory

$21.75M

-6.8%

Long Term Debt

$40.88M

-81.8%

Short Term Debt

$189.61M

+926.2%

Return on Assets

10.10%

N/A

Return on Invested Capital

-7.28%

N/A

Free Cash Flow

-$6.55M

+22.2%

Operating Cash Flow

$3.74M

+186.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CODICompass Diversified

CODICompass Diversified$10.03+1.21%

KFRCKforce Inc.

KFRCKforce Inc.$55.12-2.77%

EBFEnnis, Inc.

EBFEnnis, Inc.$21.58+1.17%

FWRDForward Air Corporation

FWRDForward Air Corporation$15.25-1.49%

SRTAStrata Critical Medical, Inc.

SRTAStrata Critical Medical, Inc.$5.04-0.98%

MTRXMatrix Service Company

MTRXMatrix Service Company$12.34-3.82%

ZIPZipRecruiter, Inc.

ZIPZipRecruiter, Inc.$3.90+1.04%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$92.32-0.08%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.42-0.04%

ONDSOndas

ONDSOndas$7.80-0.02%

TAT&T

TAT&T$24.13+0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.48+0.07%

CLFCleveland-Cliffs

CLFCleveland-Cliffs$11.93+0.09%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.00-0.03%

Questions About CYRX

What is the current price of Cryoport?

Cryoport is trading at $15.35 per share.

What is the 52-week range for Cryoport?

Over the past 52 weeks, Cryoport has traded between $6.69 and $16.89.

How much debt does Cryoport have?

As of the most recent reporting period, Cryoport reported total debt of $230.49M.

How much cash does Cryoport have on hand?

Cryoport reported $272.91M in cash and cash equivalents in its most recent financial results.

What is Cryoport’s dividend yield?

Cryoport does not currently have a dividend yield.

Cryoport(NASDAQ) CYRX

Cryoport Financials at a Glance

CYRX News

Cryoport (CYRX) Q2 Revenue Jumps 14%

CEO Jerrell Shelton Sells Some Shares of Cryoport (CYRX)

Why Shares of Cryoport are Tumbling Thursday

2 Ultra-High-Growth Healthcare Stocks That Are Just Getting Started

Why Cryoport Stock Is Up 39% Since Yesterday and Chart Industries Stock is Down

Why Cryoport Stock Just Dropped 16%

CYRX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cryoport

How They Help

Scaling the Global Network

Ensuring Medical Safety

The Financial Record

Evolution of the Business

CYRX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cryoport Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CYRX

What is the current price of Cryoport?

What is the 52-week range for Cryoport?

How much debt does Cryoport have?

How much cash does Cryoport have on hand?

What is Cryoport’s dividend yield?

Premium Investing Services